Only about 27% of patients newly diagnosed with focal epilepsy are seizure-free on initial anti-seizure medications, new ...

Biohaven Ltd.’s BHV-7000, a selective Kv7.2/7.3 potassium channel activator, is in phase II/III development for the treatment ...

The focal seizures initially occurred weekly and progressed to generalized tonic–clonic seizures. During the subsequent 15 years, the patient received treatment with various medications and ...

UC San Diego is among more than 100 locations nationwide participating in new clinical trials for a drug that shows promise ...

Epidiolex is showing positive results for treating TSC, adding to its success with addressing Dravat Syndrome and Lennox ...

Diversity levels were even lower among people with epilepsy in these studies, as only about 8% were non-European (6.4% East ...

Background. A 20-year-old woman was referred to our intensive care unit with a high frequency (every 1–2 min) of focal motor seizures. She had been diagnosed as having biopsy-proven Rasmussen ...

generalized seizures and focal or partial seizures. Partial seizures, also called focal or localized seizures, are limited to one hemisphere of your brain. When a partial seizure happens ...

Epilepsy, a prevalent neurological disorder, arises from abnormal electrical activity in the brain, leading to seizures. These seizures manifest in various forms, impacting individuals differently.

A seizure is caused by an abnormal change in the brain’s electrical activity. The cause is often an event or condition that disrupts the communication between neurons in the brain. If you’re ...

(Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced new compelling ...

Five posters to be presented including new long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in FOS and findings around ...